Non-antisense oligonucleotide approaches for experimental treatment of glioblastoma.
Neckers
L M
LM
Medicine Branch, NCI, NIH, Rockville, MD 20850, USA.
Kanekal
M
M
Connell
Y
Y
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000235:genetics / Q000628:therapy*; D003342:Corpus Striatum; D018899:CpG Islands; D016207:Cytokines / Q000096:biosynthesis / Q000235:genetics; D004354:Drug Screening Assays, Antitumor; D016228:Endothelial Growth Factors / Q000037:antagonists & inhibitors; D005346:Fibroblast Growth Factors / Q000037:antagonists & inhibitors; D005786:Gene Expression Regulation / Q000187:drug effects; D015316:Genetic Therapy; D005909:Glioblastoma / Q000235:genetics / Q000628:therapy*; D006131:Growth Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008222:Lymphokines / Q000037:antagonists & inhibitors; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D009838:Oligodeoxyribonucleotides / Q000627:therapeutic use*; D016337:RNA, Catalytic / Q000627:therapeutic use*; D051381:Rats; D011923:Rats, Nude; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D016207:Cytokines; D016228:Endothelial Growth Factors; D006131:Growth Inhibitors; D008222:Lymphokines; D009838:Oligodeoxyribonucleotides; D016337:RNA, Catalytic; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D005346:Fibroblast Growth Factors